Last updated: 21 July 2019 at 11:27pm EST

International Inc & Subsidi... Net Worth




The estimated Net Worth of International Inc & Subsidi... is at least $4.92 Million dollars as of 27 February 2004. International Subsidi owns over 16,000 units of Cerus stock worth over $4,495,035 and over the last 21 years International sold CERS stock worth over $423,675.

International Subsidi CERS stock SEC Form 4 insiders trading

International has made over 5 trades of the Cerus stock since 2004, according to the Form 4 filled with the SEC. Most recently International sold 16,000 units of CERS stock worth $62,080 on 27 February 2004.

The largest trade International's ever made was selling 37,000 units of Cerus stock on 20 February 2004 worth over $144,670. On average, International trades about 21,460 units every 3 days since 2004. As of 27 February 2004 International still owns at least 2,192,700 units of Cerus stock.

You can see the complete history of International Subsidi stock trades at the bottom of the page.



What's International Subsidi's mailing address?

International's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.

Insiders trading at Cerus

Over the last 21 years, insiders at Cerus have traded over $5,083,598 worth of Cerus stock and bought 1,382,745 units worth $4,903,526 . The most active insiders traders include William Mariner Greenman, Laurence M Corash, and Bruce C Cozadd. On average, Cerus executives and independent directors trade stock every 33 days with the average trade being worth of $90,805. The most recent stock trade was executed by Kevin Dennis Green on 3 September 2024, trading 82,657 units of CERS stock currently worth $178,539.



What does Cerus do?

cerus corporation is a biomedical products company focused on commercializing the intercept blood system to enhance blood safety. the intercept system is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. the nucleic acid targeting mechanism of action enables intercept treatment to inactivate established transfusion threats, such as hepatitis b and c, hiv, west nile virus and bacteria, and is designed to inactivate emerging pathogens such as influenza, malaria and dengue. cerus currently markets and sells the intercept blood system for both platelets and plasma in europe, russia, the middle east and selected countries in other regions around the world. the intercept red blood cell system is in clinical development.



What does Cerus's logo look like?

Cerus Corp. logo

Complete history of International Subsidi stock trades at Cerus

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
27 Feb 2004 International Inc & Subsidi...
10% owner
Sale 16,000 $3.88 $62,080
27 Feb 2004
2,192,700
24 Feb 2004 International Inc & Subsidi...
10% owner
Sale 4,800 $3.90 $18,720
24 Feb 2004
2,208,700
20 Feb 2004 International Inc & Subsidi...
10% owner
Sale 37,000 $3.91 $144,670
20 Feb 2004
2,213,500
18 Feb 2004 International Inc & Subsidi...
10% owner
Sale 25,000 $3.92 $98,000
18 Feb 2004
2,250,500
12 Feb 2004 International Inc & Subsidi...
10% owner
Sale 24,500 $4.09 $100,205
12 Feb 2004
2,275,500


Cerus executives and stock owners

Cerus executives and other stock owners filed with the SEC include: